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Purpose: To develop sustained release matrix tablets of diltiazem hydrochloride (DTZ) using modified 
karaya gum (MK). 
Methods: MK was prepared by cross-linking karaya gum with tri-sodium tri-metaphosphate (STMP) 
which was used as a cross linker. Matrix tablets of DTZ were prepared using varying ratios of 
unmodified karaya gum (K) and MK by direct compression. The matrix tablets were evaluated for 
pharmacotechnical properties and in vitro release. The optimized formulation was compared with a 
reference, Dilzem® SR. MK and the formulations were also characterized by scanning electron 
microscopy (SEM), Fourier transform infra-red spectroscopy (FTIR) and differential scanning calorimetry 
(DSC). 
Results: Tablets formulated with MK showed higher mean dissolution time (MDT) and lower dissolution 
efficiency than those prepared with karaya gum. Drug release was by water uptake, diffusion and 
erosion mechanisms. Drug release for tablets prepared with pure K was 99.9 % at the end of 10 h while 
that tablet made with MK was 68.2 % at the end of 12 h. MK sufficiently controlled the drug release 
unlike K which exhibited rapid drug release efficiency. SEM images of the tablets before and after 
dissolution showed some morphological changes on the tablet surface while FTIR and DSC thermogram 
studies confirmed that there was no chemical interaction between the drug and the polymers in MK 
formulation. Formulation F6 compared well with Dilzem® SR (reference) (p < 0.05) in terms of release 
characteristics.  
Conclusion: The results of the study demonstrate that modified karaya gum is a potential matrix 
material for formulating suitable sustained-release matrix tablets of diltiazem. 
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Of the approaches used for controlling drug 
release from solid dosage forms, compressed 
matrices continue to attract considerable 
attention, as such devices low-cost and high 
levels of drug can be incorporated in them. 
Hydrophilic polymers are widely used in the 
formulation of modified release dosage forms 
because they are low-cost, and usually show 
reduced risk of systemic toxicity and minimal 
incidence of dose dumping.  Matrix systems 
can be used to control the release of both 
water soluble and water insoluble drugs. 
Although, their drug release behavior 
appears simple, but in reality, the release 
pattern is a complex phenomenon. At the 
molecular level, it involves water penetration, 
polymer water uptake, as well as drug 
dissolution and diffusion as well as polymer 
water uptake and erosion [1,2].  
 
In recent years, researchers have become 
increasingly interested in the utilization of 
biopolymers due to their wide ranging 
advantages over synthetic polymers. 
Polysaccharide gums are the materials of 
choice because they are naturally abundant, 
biocompatible, biodegradable, and non-
immunogenic [3,4].    
 
Gum karaya, sometimes called as sterculia 
gum is a complex water-soluble 
polysaccharide. It is a hydrophilic colloid 
prepared from the exudates of Sterculia 
urens tree. It is a partially acetylated complex 
polysaccharide composed of galacturonic 
acid, beta-D-galactose, glucuronic acid, L-
rhamnose, and other residues obtained as 
the calcium and magnesium salt [5]. As a 
bulk laxative, gum karaya is second only to 
psyllium seeds in importance [6]. When used 
in bulk laxatives, the gum is usually 
processed to 500 µ mean particle size. These 
coarse gum particles absorb water and swell 
60 to 100 times their original volume, forming 
a discontinuous type of mucilage. This type of 
mucilage is very effective as a laxative. The 
gum has been evaluated as a controlled 
release-matrix and has also shown superior 
mucoadheshion to guar gum [7]. Modification 
of karaya gum to develop matrix tablets has 
been reported on extensively in the literature; 
except for a few works using them as 
retarding polymers, not much has been done 
[8]. 
 
Tri-sodium tri-metaphosphate (STMP) is a 
non-toxic cyclic triphosphate, already 
reported as an effective cross-linker of 
starches [9], guar gum [10] and hyaluronic 
acid [11] in order to synthesize gels for 
pharmaceutical purposes.  
 
Diltiazem hydrochloride (DTZ) is a calcium 
channel blocker that is widely prescribed for 
the treatment of hypertension and angina. It 
is highly water soluble and almost completely 
absorbed. However, its bioavailability is only 
30 to 40 % owing to first pass metabolism, 
and has an elimination half-life of 3.5 h. 
Therefore, DTZ requires multiple daily dosing 
to maintain adequate plasma concentrations. 
The drug is thus a suitable model candidate 
for sustained drug delivery [12].  
 
The objective of the present study was to 
modify karaya gum using STMP as cross 
linking    agent and also to evaluate the 
modified karaya gum as a suitable, release 
retardant polymer for the formulation of 






Diltiazem hydrochloride (DTZ) and 
microcrystalline cellulose (MCC) were 
obtained free of charge from Micro Lab Ltd, 
Bangalore, India. Karaya gum (K) and tri-
sodium tri-metaphosphate (STMP) were 
purchased from Sigma Aldrich, Steinheim, 
Germany, while magnesium stearate, 
hydrochloric acid, sodium hydroxide, and 
potassium dihydrogen phosphate were all 
obtained from Merck, Mumbai, India. All 
chemicals and reagents used were either of 
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pharmaceutical or analytical grades. The 
reference diltiazem hydrochloride tablet 
formulation used for the study was Dilzem SR 
(Torrent Pharma Ltd, India). 
 
Synthesis of modified karaya gum(MK)  
 
Karaya gum was cross-linked with tri-sodium 
tri-metaphosphate (STMP) as follows: STMP 
(1 g) was dissolved in 50 ml of water and 
added to 5 ml of 0.1M NaOH in a 200 ml 
beaker with 1 g of karaya gum in 50 ml of 
water then added slowly with stirring. The 
reaction mixture containing 100ml was stirred 
for a 2 h, poured into five Petri dish,  each 
containing 20 ml,  and dried at 60 0C for 24 h.  
The dried complex (modified gum) was 
powdered, passed through a 200 µ aperture 
sieve and used for the formulation of tablets. 
 
Preparation of matrix tablets 
 
Matrix tablets of 90 mg diltiazem 
hydrochloride were prepared (based on the 
composition in Table 1) by direct 
compression method. The excipients (except 
magnesium stearate) and drug were first 
passed through a 200 µ aperture sieve and 
then mixed in geometrical fashion for 10 min. 
Finally, the magnesium stearate was added 
and mixed for additional 2 min. The batch 
size of each formulation was 50 tablets. The 
tablets were compressed in a tablet machine 
(Rimek Mini Press I, Mumbai, India) using 12 
mm flat-faced punches [13]. 
 
Physicochemical characterization of 
tablets  
 
The hardness and friability of the tablets of 
tablets were measured with a digital 
hardness tester (Erweka, Mumbai, India) and 
friabilator (Electrolab, Mumbai, India), 
respectively. Content uniformity of DTZ of all 
batches (10 tablets) was analyzed 
spectrophotometrically (model UVPC 1601, 
Shimadzu, Kyoto, Japan) at 237 nm. 
 
Weight variation and uniformity of drug 
content were assessed for 20 tablets 
according to Indian Pharmacopoeia (IP) 
procedures [14]. Twenty tablets were 
weighed individually and the mean weight 
determined.   The tablets were then 
powdered, and 100 mg equivalent of the 
tablet triturate taken in a 100 ml volumetric 
flask. The volume was made up to mark with 
simulated gastric fluid (pH 1.2) to give Stock I 
solution.   Stock I solution (10 ml) was 
transferred to 100 ml volumetric flask and 
diluted up to the mark with buffer (Stock 
solution II), 3ml of which was diluted to 25 ml 
and the solution was filtered through 0.45 µm 
pore membrane. Its absorbance was 
measured spectrophotometrically (model 
UVPC 1601, Shimadzu, Kyoto, Japan) at 237 
nm.  
 
Scanning electron microscopy (SEM)  
 
The surface morphology of the matrix tablets 
was analyzed with a scanning electron 
microscope (model JSM-840A, Jeol,Japan) 
before hydration and 6 h after.  
 
Water uptake and erosion studies  
 
Water uptake and mass loss were computed 
gravimetrically according to Eqs 1 and 2. 
Three tablets were used per time point. At the 
predetermined times, the tablets were lightly 
patted with tissue paper to remove excess 
surface water. The swollen weight of tablets 
was determined(Ts) and then the same 
tablets were dried in a vacuum oven at 40 °C 
for 48 h, the remaining dry weight of the 
tablet (Tf) was determined. The study was 
carried out in triplicate. Water uptake (%) and 
erosion (%) was calculated using Eqs 1 and 
2, respectively [15]. 
 
Water uptake (%) = (Ts – T)/T x 100  ..…  (1) 
where Ts is the weight of the swollen tablet 
and T is the initial of the tablet, i.e., prior to 
the test. 
 
Erosion (%) = (T – Tf)/Tf x 100   ………..  (2) 
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where T is the initial weight of the tablet and 




FT-IR studies were carried out using 
Shimadzu FTIR 8400S. The pellets were 
prepared with KBr using pure drug, polymers 
and crushed tablet formulations. Spectra 




Thermal analysis of samples were carried out 
with a DSC; Perkin-Elmer, Pyris-1. The 
analysis was performed on 2 - 4 mg of the 
drug alone, the polymer and a mixture of the 
drug and polymer in the range of 0 – 400 0C. 
The samples were placed in zn aluminium 
pan with a perforated, under nitrogen 
atmosphere and heating rate of 10 0C/min.   
 
In vitro release studies  
 
Dissolution test was carried out using a USP 
type I apparatus (model TDT-08l, Electrolab, 
Mumbai, India) at 100 rpm and 37 °C for the 
first 2 h in 900 mL of simulated gastric fluid 
(0.1M HCl) and immediately continued in 900 
mL of phosphate buffer (pH 7.4). Five ml of 
the dissolution fluid was withdrawn at regular 
time intervals during the studies and replaced 
with an equal volume of drug-free dissolution 
fluid to maintain sink conditions. The samples 
were suitably diluted with fresh dissolution 
fluid and analyzed for drug release 
spectrophotometrically at 237 nm.  
 
Kinetic analysis of dissolution data  
 
To study the mechanism of drug release from 
the matrix tablets, the release data were fitted 
to zero-order, first-order, and Higuchi models. 
The data were also subjected to the 
Korsmeyer-Peppas exponential equation (Eq 
3) which is often used to describe drug 
release behavior from polymeric systems.  
   ( ) nLogtLogkMMLog ft += …….  (3)  
Where ft MM is the fractional release of 
drug, k is constant, ni s the diffusional 
exponent, and t is time. 
 
The diffusional exponent, ‘n’, which is 
indicative of the mechanism of drug release, 
was obtained by plotting the log value of 
percent drug released against log time for 
each batch (Eq 3). A value of n = 0.45 
indicates Fickian (case I) release; > 0.45 but 
< 0.89 is non-Fickian (anomalous) release; 
and > 0.89 indicates super case II type of 
release. Case II generally refers to the 
erosion of the polymeric chain while 
anomalous transport (non-Fickian) refers to a 
combination of both diffusion and erosion 
controlled-drug release. Dissolution efficiency 
(DE), defined as the area under the 
dissolution curve up to a certain time t, and 
expressed as a percentage of the area of the 
rectangle described by 100 % dissolution in 
the same time, and mean dissolution time 
(MDT), were used to translate the profile 
differences into a single value as shown in 
Eqs 4 and 5 [16,17]. 












MDT is a measure of the dissolution rate: the 


















where i is the dissolution sample number, n is 
the number of dissolution sample time, tmid is 
the time at the midpoint between i and i-1, 
and ∆M is the amount of drug dissolved 
between i and i-l. The similarities between 
two dissolution profiles were assessed by a 
pair-wise model-independent procedure, 


































                                                                          
where n is the number of pull points, Rt is the 
reference profile at time point t, and Tt is the 
test profile at the same time point; the value 
      
………………………………………………………………..
………… (5) 
…..  (6) 
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of f2 should be between 50 and 100. An f2 
value of 100 suggests that the test and 
reference profiles are identical and, as the 
value becomes smaller, the dissimilarity 
between release profiles increases [18].  
Statistical analysis 
 
Comparison among the developed 
formulation and the reference formulation 
(Dilzem- SR) was carried out by Student t-





Characterization of tablets 
 
The drug content of the formulations was 
uniform, being more than 97 % and with less 
than 1.0 % relative standard deviation. 
Hardness ranged from 4 - 6 kg/cm2 while 
friability was < 1 %. Thus, all the tablet 
formulations showed acceptable physical 
characteristics. 
 
In vitro drug release and kinetics  
 
The in-vitro release results are shown in 
Figure 1. Drug release of diltiazem 
hydrochloride from all the formulations in the 
first hour ranged from 16.8 to 86.6 % while 
after 12 h, it was between 68.2 and 100.0 %. 
Increase in the content of polymer decreased 
drug release at the 12th hour.. Burst effect 
was observed at the 1st hour only in 
formulations containing low polymer 
concentration. Formulations containing 
unmodified karaya gum showed complete 
drug release in < 12 h whereas those 
formulated with modified karaya gum 
exhibited extended drug release over the 12 
h period. Both the test formulation and the 
reference showed similar release rates 





Figure 1:  Dissolution profile of formulations (Key: 
 = F1;  = F2;  = F3;  = F4; =F5;  = F6; 
 = F7; = F8; = reference standard) 
 
The dissolution kinetic data, mean dissolution 
time (MDT) and dissolution efficiency (DE12) 
of the formulation are shown in Table 1. MDT 
ranged from 0.55 – 3.36 h while DE12 (at the 
end of 12 h) was 46.0 – 86.5 %. The drug 
release data of the tableted formulations did 
not fit satisfactorily to zero-order, first-order 
but showed good fit into the Korsmeyer 
equation (r2 = 0.8346 to 0.9924) and Higuchi 
equation (r2 = 0.860 to 0.9916), respectively. 
The value of the release exponent, “n”, for 
the various matrices ranged from 0.0258 to 
0.4935. F6 had MDT and dissolution 
efficiency (DE12 %) similar to those of the 
standard product, Dilzem SR. The similarity 
factor (f2) was 68.75, suggesting that their 
dissolution profiles were very similar. Of all 
the formulations, only F6 did not significantly 
differ in terms of drug release (p < 0.05) from 
the commercial DTZ product used as 
standard.  
 




       K MK MCC n KP a Higuchi MDT(h) ± 
SD 
DE12  
± SD (%) 
     100 
      75 
      50 
      25 
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Note: KP = Korsemeyer-Peppas; talc:magnesium. stearate (5 mg/tablet) in the ratio of 2:1 was added as glidant-lubricant to all the tablet 
formulations 
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Scanning electron microscopy (SEM) 
 
Figure 2 displays the scanning electron 
micrographs (SEM) of the surface of tablet 
formulation F6. The micrographs indicate that 
the surface of the matrix tablet became highly 
porous after the dissolution. 
                         
 
 
Figure 2 : Scanning electron micrographs of 
tablet formulation F6 before (A) and 6 h after 
(B) dissolution 
 
Water uptake and erosion 
 
Figure 3 shows the water uptake and erosion 
profiles for the optimized formulation F6 
contained modified karaya gum and the 
reference (standard) tablets. At the end of 12 
h water uptake for the test formulation and 
reference standard was 165.5 and 250 %, 
respectively, while erosion was 36.75 and 




As observed from the Figure 4, the pure 
karaya gum peaks are associated to the 
hydrogen bonded OH groups, two peaks are 
indicative of acetyl groups and the other two 
peaks are attributed to COO- groups of 
uronic acid residues. In modified karaya gum, 
the stunted broadened peak which appeared 
at 3428 cm-1 is attributed to the overlap of N-
H stretching band of amide group and O-H 
stretching band. Disappearance of acetyl 
groups in modified gum is also observed. The 
appearance of new peaks which were absent 
in karaya gum are attributed to phosphate-I (-
C=O stretching) and phosphate-II (-C-O 
bending) of the phosphate group of STMP 
thus confirming the cross-linking reaction. 
The FTIR spectra of pure drug and 
formulation F6 showed characteristic peaks 
for both pure DTZ and DTZ in the test matrix 
formulation without any significant shift in 
their positions.  
                          
 
 
Figure 3: Water uptake and eroding behaviour of 






Figure 4: A = FT-IR spectra of a) unmodified 
karaya gum, b) modified karaya gum, c) F6 and d) 
pure drug; B = DSC thermograms of unmodified 
karaya gum, modified karaya gum, F6 and pure 




As Fig 4B indicates, the DSC thermograms of 
unmodofied karaya gum (K) showed 
endothermic peaks at 85.3 and 186.7 oC, but 
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modified karaya gum (MK) showed an 
endothermic peak at 85.3 oC and a new 
exothermic peak at 259.4 oC. The DSC 
thermograms of formulation F6 and pure DTZ 
showed endothermic peaks for the pure drug 
and the drug in the formulation at 216.4 and 




Drug release  
 
The rate of drug release tended to decrease 
with increase in the amount of polymer. This 
is in agreement with previous works which 
suggested that the viscosity of the gel layer 
around the drug particles in the tablet 
increases with increase in hydrogel 
concentration thus limiting the release of the 
drug [19]. The gel formed during the 
penetration of dissolution media into the 
matrix structure, consists of closely packed 
swollen particles. With further increase in 
polymer content, thicker gel forms, inhibiting 
the dissolution fluid penetration and resulting 
in significant reduction in drug release 
(compare F5 and F6 with other test 
formulations). Formulations with low polymer 
concentrations as well as unmodified karaya 
gum rapidly hydrated and formed weak 
matrix systems which accounted for the 
‘burst’ release as well as rapid release.  
Furthermore, crosslinking in the modified 
karaya gum resulted in matrix rigidity, thereby 
slowing the hydration rate of the gum; this, in 
conjuction with erosion, resulted in controlled 
release of drug which was incomplete at the 
of 12 h. Among the test formulations, F6 was 
most similar to the standard product, Dilzem 
SR, with a similarity factor of 68.75. The 
release data showed close affinity to the 
Korsmeyer-Peppas model. The release 
exponent “n” value was characteristic of 
Fickian diffusion and indicated a combined 
effect of diffusion and erosion mechanisms 
for controlled drug release.   
 
The SEM photomicrograph of the tablets after 
6 h after hydration commenced showed a 
highly porous tablet surface which suggest a 
porous tablet matrix structure. This confirms 
that drug release was by diffusion from the 
tablet core to the surface. Since the gel layer 
undergoes surface erosion, it is possible that 
the inner porous network is exposed after the 
erosion-dissolution of the outer layer of the 
matrix. The presence of both pores and gel 
structure on the tablet surface indicates 
involvement of both erosion and diffusion 
mechanisms for sustained drug release. 
 
Thus the matrices underwent both water 
uptake and erosion simultaneously 
immediately after placement in the dissolution 
medium and this continued over the 12 h 
period of the study. Formulation F6 and the 
standard DTZ product had overlapping 
erosion profile but their water uptake 
behaviour was similar only up to the 6th hour. 
The plots were almost linear, indicating a 
balance between water uptake and erosion, 
and resulting in sustained drug release [20]. 
The DSC thermogram of MK, when 
compared to pure karaya, showed a main 
broad endothermic peak. But the other peak 
which appeared at 186.7oC disappeared 
withthe appearance of a new exothermic 
peak. Thus the above data obtained indicates 
a change in the structure of karaya gum. 
Also, the DSC endothermic peaks for the 
pure drug and the drug in the formulation F6 
showed only a negligible shift in their 
positions with some peak broadening in the 
latter. Thus it seems from both FT-IR and 
DSC results that karaya gum structure was 
modified by crosslinking, and that the 
likelihood of any chemical interaction 
between the drug and the polymers does not 
exist. 
 
CONCLUSION   
 
This study demonstrates the crosslinking of 
karaya gum enhances matrix rigidity, thereby 
sustaining drug release rate when compared 
to natural gum. Although karaya gum 
structure was modified by crosslinking, there 
was no any chemical interaction between the 
drug and the polymers used. Overall, the 
results of the study indicate that modified 
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karaya gum would be suitable for formulating 
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